Amneal Pharmaceuticals (AMRX) Net Income Growth (5y) (2022 - 2026)
Amneal Pharmaceuticals (AMRX) Net Income Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.88 Bn | 32.14 Bn | 1.97 Bn |
| 3 | Zoetis | 32.64 Bn | 30.70 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.04 Bn | 20.88 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.37 Bn | 18.57 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.45 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Amneal Pharmaceuticals | 5.67 Bn | 5.67 Bn | 320.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.00% |
| Dec 31, 2025 | 55.06% |
| Sep 30, 2025 | 23.07% |
| Jun 30, 2025 | 28.47% |
| Mar 31, 2025 | -27.34% |
| Dec 31, 2024 | 20.40% |
| Sep 30, 2024 | 15.24% |
| Jun 30, 2024 | 18.48% |
| Mar 31, 2024 | 8.18% |
| Dec 31, 2023 | -35.09% |
| Sep 30, 2023 | 7.47% |
| Jun 30, 2023 | 16.20% |
| Mar 31, 2023 | -17.04% |
| Dec 31, 2022 | -15.93% |
| Sep 30, 2022 | -15.86% |
| Jun 30, 2022 | -52.94% |